跳至主要内容
临床试验/CTRI/2024/07/070640
CTRI/2024/07/070640尚未招募2 期

A Randomized, Parallel Group, Open Label, Active Controlled Clinical Study to evaluate the Safety and Efficacy of a combination of oral and topical Unani Formulations in the Management of Waja‘ al-Maf ?s?il (Osteoarthritis Knee) - NI

ational Research Institute of Unani Medicine for Skin Disorders0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients of any sex aged between 40to 65years
  • 2.Clinical and Radiographic Knee Osteoarthritis as per the following
  • American College of Rheumatology (ACR) criteria:
  • a. Knee Pain
  • b. Osteophytes on Knee Radiograph, and
  • c. At least 1 of the following 3 criteria:
  • i. Age =40 years
  • ii. Morning Stiffness lasting =30 minutes
  • iii. Crepitus on Active Knee Motion
  • 3.Knee OA of Kellgren-Lawrence Grade 1 to 3
  • 4.Participants who are able and willing to comply with the protocol and to sign IEC approved ICF

排除标准

  • 1.Knee OA of Kellgren-Lawrence grade IV
  • 2. Secondary OA, Inflammatory joint diseases (e.g. RA, psoriatic arthritis, gout), or any other type of arthritis
  • 3.Patients on long-term steroid treatment
  • 4.H/o having received intra-articular knee injection (corticosteroids or hyaluronan), or any investigational drug in the previous one month
  • 5.Pregnant or Lactating Women
  • 6.Significant Pulmonary/Cardiovascular/Hepato-renal Dysfunction
  • 7.Known cases of Immunocompromised states (HIV/ AIDS, etc.)/ Malignancies

研究者

发起方
ational Research Institute of Unani Medicine for Skin Disorders

相似试验